Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert Grant Edwards currently holds 2,609 shares of Sonoma Pharmaceuticals, Inc. (SNOA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Grant Edwards has been a net neutral trader of SNOA stock. They have purchased $0 and sold $0 worth of shares.
Robert Grant Edwards's most recent insider trade was on Apr 23, 2020, when they sold 2,609 shares at $0.00 per share.
Robert Grant Edwards serves as Executive at Sonoma Pharmaceuticals, Inc. (SNOA). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Robert Grant Edwards holds the position of Executive at Sonoma Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Robert Grant Edwards has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Robert Grant Edwards was on Apr 23, 2020, when they purchased $0 worth of SNOA shares. This transaction involved 2,609 shares at N/A per share.
Robert Grant Edwards currently owns 2,609 shares of Sonoma Pharmaceuticals, Inc. (SNOA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert Grant Edwards's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert Grant Edwards has 1 Form 4 filings on record as an insider at Sonoma Pharmaceuticals, Inc..
Set alerts for Robert Grant Edwards and 40,000+ other insiders.